An expert panel of India's central drug authority has recommended against granting permission to the Serum Institute of India (SII) for conducting phase 2/3 trial of Novavax's Covid-19 vaccine 'Covovax' on children, reported news agency PTI quoting sources. <br />As per the report, the Subject Expert Committee (SEC) has stated that the vaccine has not been approved in any country.
